Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Touyun Biotech GroupHKSE:01332 +5.41%22 Days Inventory is 124.68 as of Dec. 2025, which is 93% above its 10-year median of 64.56. GuruFocus rates HKSE:01332 with a GF Score™ of 22/100 and a GF Value™ of HK$0.16 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 382 Packaging & Containers companies, Touyun Biotech Group ranks worse than 85.34% on this metric.
The historical rank and industry rank for Touyun Biotech Group's Days Inventory or its related term are showing as below:
HKSE:01332'
s Days Inventory Range Over the Past 10 Years
Min: 28.34 Med: 64.56 Max: 159.52
Current: 149.14
During the past 13 years, Touyun Biotech Group's highest Days Inventory was 159.52. The lowest was 28.34. And the median was 64.56.
HKSE:01332's Days Inventory is ranked worse than 85.34% of 382
companies
in the Packaging & Containers industry
Industry Median: 77.55
vs HKSE:01332: 149.14
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Touyun Biotech Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.46.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Touyun Biotech Group (HKSE:01332) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Touyun Biotech Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Touyun Biotech Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Touyun Biotech Group Days Inventory Related Terms
Touyun Biotech Group Days Inventory Historical Data
* Premium members only.
The historical data trend for Touyun Biotech Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01332 vs SW, PKG, IP: Days Inventory Comparison
For the Packaging & Containers subindustry, Touyun Biotech Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touyun Biotech Group Days Inventory vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Touyun Biotech Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Touyun Biotech Group (HKSE:01332) has a Days Inventory of 124.68 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Touyun Biotech Group and its competitors. This is 93% above median its historical median of 64.56. Over the past decade, Touyun Biotech Group's Days Inventory has ranged from 28.34 to 159.52. According to the industry distribution chart, Touyun Biotech Group ranks #326 out of 382 companies in the Packaging & Containers industry, placing it in the top 85.3%.
Is Touyun Biotech Group's Days Inventory too high?
Touyun Biotech Group's current Days Inventory of 124.68 is 93% above median its 10-year median of 64.56. Over the past 10 years, this metric has ranged from a low of 28.34 to a high of 159.52. The Packaging & Containers industry median Days Inventory is 77.55. Touyun Biotech Group's value of 124.68 is 60.8% above this industry median. Based on the distribution chart, Touyun Biotech Group ranks #326 out of 382 companies in the Packaging & Containers industry, which is in the bottom quartile relative to peers. Overall, Touyun Biotech Group has a GF Score™ of 22/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's Days Inventory compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Touyun Biotech Group ranks #326 out of 382 companies for Days Inventory. This places Touyun Biotech Group in the lower half of its industry. The industry median Days Inventory is 77.55. Touyun Biotech Group's value of 124.68 is 60.8% above this benchmark. Historically, Touyun Biotech Group's own Days Inventory has ranged from 28.34 to 159.52 over the past decade. While the company's 10-year median is 64.56 vs. the industry median of 77.55, Touyun Biotech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Packaging & Containers company?
The median Days Inventory among Packaging & Containers companies is 77.55, based on 382 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touyun Biotech Group's current Days Inventory of 124.68 is 60.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Touyun Biotech Group and its competitors. For the Packaging & Containers industry, the median Days Inventory is 77.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touyun Biotech Group's current Days Inventory is 124.68, which is 93% above median its own 10-year median of 64.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.16 — trading 2.5% below its estimated fair value. The current Days Inventory is 124.68, which is 93% above median its 10-year median of 64.56 and 60.8% above the Packaging & Containers industry median of 77.55. Touyun Biotech Group's overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current Days Inventory is 124.68 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?
Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued.
The current stock price of HK$0.16 is trading 2.5% below its estimated GF Value™ of HK$0.16.
GuruFocus considers Touyun Biotech Group to be Modestly Undervalued.
Key valuation signals for HKSE:01332:
Days Inventory: 124.68 (93% above median its 10-year median of 64.56)
GF Value™: HK$0.16 vs. price of HK$0.16 (2.5% below fair value)
Industry Position: 60.8% above the Packaging & Containers median (#326 of 382)
No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
22GF Score
Get the complete analysis for HKSE:01332
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01332 has been successfully added to your 
